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Abstract
Background: Stroke patients may present severe cognitive impairments, primarily related to executive functions.
Transcranial direct current stimulation has shown promising results, with neuromodulatory and neuroplastic effects.
This study is a double-blind, sham-controlled clinical trial aiming to compare the long-term effects of stimulation in
two different cognitive regions after a stroke.
Methods/Design: Sixty patients who suffer from chronic strokes will be randomized into one of four groups:
dorsolateral prefrontal cortex, cingulo-opercular network, motor primary cortex and sham stimulation. Each group
will receive transcranial direct current stimulation at an intensity of 2 mA for 20 minutes daily for 10 consecutive
days. Patients will be assessed with a Dysexecutive Questionnaire, Semantic Fluency Test, categorical verbal fluency
and Go-no go tests, Wechsler Adult Intelligence Scale, Rey Auditory-Verbal Learning Test, Letter Comparison and
Pattern Comparison Tasks at baseline and after their tenth stimulation session. Those who achieve clinical improvement
with neurostimulation will be invited to receive treatment for 12 months as part of a follow-up study.
Discussion: Long-term stimulation could be analyzed in regard to possible adaptive changes on plasticity after
structural brain damage and if these changes are different in terms of clinical improvement when applied to two
important cognitive centers.
Trials registration: Clinicaltrials.gov, NCT02315807. 9 December 2014.
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Background
Because cerebrovascular diseases are considered a
major factor of mortality and morbidity in many parts
of the world, new therapeutic methods have been pro-
posed for the management of cognitive sequelae after a
stroke. However, few studies have examined cognitive
factors associated with treatment by neurostimulation
after a stroke. More emphasis has been directed at
functional improvement related to outcomes such as
mobility, independence and daily living activities [1]. In
contrast, it is estimated that 75 % of people will have
losses in executive functions after a stroke. These diffi-
culties cause problems in their abilities to perform day-
to-day tasks and deal with other problems such as
movement disorders, which are also derived from their
brain injury [2].
Neurostimulation techniques such as transcranial
magnetic stimulation (TMS) and transcranial direct
current stimulation (tDCS) have shown promising re-
sults in this population [3]. Both techniques can lead to
an improvement of lost skills/abilities, with virtually no
side effects or discomfort for patients [4]. Regarding
tDCS, there are numerous advantages compared to
other non-invasive brain stimulation therapies, such as
low cost, easy handling and high portability. During the
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application of electric current, essential neurostimulatory
effects are observed. After stopping tDCS application,
neuroplastic effects can be observed [5].
With regard to the stimulation site of cognitive areas,
it is not yet clear what role each area would play during
the planning and execution of cognitive information
[6]. Although the dorsolateral prefrontal cortex (dlPFC)
is considered the main cognitive control area used in
experiments with tDCS [7], neuroimaging techniques
have contributed to identifying other “multiple func-
tional neural networks,” which may be related to pro-
cessing or cognitive control categories [8]. A study
involving mapping and interconnection of various re-
gions showed that the frontoparietal network could
serve as a “flexible hub” that would alter connectivity
with other neural networks based on the specific task
[9]. Other authors indicate that the parietal component
seems to initiate and adjust the control, while the
cingulo-opercular network (CON) provides a stable
maintenance of the task, suggesting connections be-
tween two core networks and other weaker long-range
connections between components [10].
In this respect, some aspects of cognition can be
broadly generalized, and there is no agreed upon list of
all components comprising executive functions (as an
example). This results in discrepancies between the
studies concerning which the factors should be re-
lated [11, 12].
To address the theoretical gaps, we propose that the
cingulo-opercular network could serve as an alterna-
tive locus of stimulation for cognitive rehabilitation of
these patients. Combined with this, this work repre-
sents the first controlled clinical trial involving the ap-
plication of tDCS on stroke. It will include a follow-up
of 12 months, making it possible to investigate not
only the effects that occur in the short term, but also
those that last for a longer period after neurostimula-
tion. In a recent study that evaluated cognitive prob-
lems after strokes in young patients (<50 years), it was
found that “mental slowness” occurs up to 10 years
after brain injury, and so it is necessary to assess the
presence of cognitive deficits after a long period of
follow-up [13].
Thus, the objective of this study is to 1) evaluate the
efficacy of tDCS on two different networks, the fronto-
parietal (specifically in the dlPFC) and the cingulo-
opercular (anterior insula/frontal operculum), compar-
ing them with each other for cognitive rehabilitation
after a chronic stroke; 2) check whether there are dif-
ferences between the benefits achieved by stimulation
of these two cortical areas and how big these differ-
ences are; and 3) present the study protocol, the previ-
ous results of the clinical trial, ensuring adherence and
compliance with the guidelines previously proposed.
Methods/Design
Design
A clinical double-blind, randomized, controlled trial will
be performed involving patients with chronic stroke,
randomly assigned to four groups: Group 1) active tDCS
in fronto-parietal region (dlPFC); Group 2) active tDCS
in the cingulo-opercular region-CON (anterior insula/
frontal operculum); Group 3) active tDCS in the primary
motor cortex (M1); and Group 4) sham tDCS in M1.
This region was used as a place of active and placebo
control.
Initially, all participants will undergo 10 consecutive
daily sessions of neurostimulation (excluding weekends).
Evaluations will be conducted pre- and post-test (T0 and
T1, respectively). After 1 month, the participants will be
checked to see who attained clinical improvement with
treatment: that is, those patients who had a final score
(T2) on the Dysexecutive Questionnaire (DEX) greater
than at least 2.77 standard error of measurement com-
pared from their baseline/initial testing [14]. Those who
have an adequate response will be invited to receive
treatment for 12 months. In this period of follow-up, the
stimulation sessions will be applied twice monthly, for 5
consecutive days. This model is similar to another that
has already been applied/used by other authors with
positive results in a study involving tDCS for treatment
of depression in order to assess whether the benefits of
regularly performed neurostimulation continue in the
long term [15]. Adverse effects will be computed period-
ically to prevent possible deleterious effects (see Fig. 1,
which demonstrates the flow of the study). Previous
studies have demonstrated that tDCS induces minimal
discomfort sensations, such as mild tingling and itching
sensations under the electrodes, predominantly in the
first few seconds of the tDCS [16, 17].
The method of randomization will be 1: 1: 1: 1, with
interchange between blocks generated by an online pro-
gram (random.org). Concealed allocation will be used
with numbered, opaque-sealed sequential envelopes so
that the person responsible for allocation will not be in
contact with patients or with the work of others. All ex-
aminers will be blind to the type of treatment the patient
is receiving (site of stimulation) and other assessments
that will be carried out. The efficiency of the masking/
blinding mechanism will be evaluated at the time of the
last interview with the evaluators. They will state what
region they believe the patient received stimulation in.
Patients will also be blinded with a masking evaluation
carried out on the last post-test where they will try to
guess in which region stimulation was applied: the main
(dlPFC) or secondary area (CON) of cognitive control,
the motor control region (M1) or sham stimulation.
Attrition will be considered when a) three alternating
or two consecutive absences; b) presence of cognitive
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comorbidities throughout the trial; c) loss during follow-
up. There will be adherence strategies administered such
as being able to make up an absence the following week,
and offering flexible schedules and frequent contact
through phone calls confirming dates of procedures and
reinforcing the importance of treatment compliance.
The study was approved by the Health Sciences Centre
Ethical Committee (#30163714.0.0000.5188) and is gov-
erned according to the principles of the Declaration of
Helsinki. To conduct the study, the informed consent of
each participating patient will be collected. The protocol
follows all the recommendations of the Standard Protocol
Items: Recommendations for Interventional Trials
Statement (SPIRIT) 2013 [18].
Participants
Sixty right-handed patients will be selected, aged be-
tween 18 and 60 years, who have been diagnosed with
stroke in the left subcortical ischemic of the middle
cerebral artery territory; according to the International
Classification of Diseases (ICD-10) and whose data have
been obtained by computerized tomography or magnetic
Fig. 1 Flow chart of study. ASB: Assessment of Stroke and other Brain Damage; CES-D: Center for Epidemiological Studies-Depression; CON:
cingulo-opercular network; DEX: Dysexecutive Questionnaire; dlPFC: dorsolateral prefrontal cortex; FAS: Semantic Fluency Test; DRS-2: Dementia
Rating Scale-2; LCPCT: Letter Comparison and Pattern Comparison Tasks; M1: primary motor cortex; MOCA: Montreal Cognitive Assessment; NIHSS:
National Institute of Health Stroke Scale; OLT: Object Learning Test; RAVLT: Rey Auditory-Verbal Learning Test; tDCS: transcranial direct current
stimulation; TMT: Trail Making Test; WAIS: Wechsler Adult Intelligence Scale
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resonance. The occurrence of the injury within a 6 to
12 month period will be considered chronic [19]. Only
those patients referred for cognitive rehabilitation based
on the clinical diagnosis by the treatment team, includ-
ing interviews and neuropsychological testing [20], will
be included in the clinical study. The neuropsychological
screen/testing will consist of the following tests [21].
The Object Learning Test [22] will be used to assess
learning and short-time memory for visually presented
material. The cutoff between normal and pathologic
cognitive functioning is 36 points for patients ≤64 years.
The Trail Making Test A [23], which will be used to as-
sess psychomotor speed and attention, has a cutoff for
normal and impaired cognitive function equivalent to
60 s. An Assessment of Stroke and other Brain Damage
[24] will be used to evaluate motor apraxia, rational
apraxia and visual-spatial ability. The present study will
be set at 65 points for motor apraxia (lower quartile), 14
points for rational apraxia (full score), and 25 points for
visual-spatial ability (lower quartile).
Exclusion criteria are as follows: inability to perform the
tests due to losses in production or understanding speech;
severe clinical status, assessed by the National Institute of
Health Stroke Scale (NIHSS) ≥16 points [25]; severe cog-
nitive comorbidities, diagnosed according to clinical
evaluation and according to the Diagnostic and Statistical
Manual of Mental Disorders, 4th. Edition (DSM-IV) [26],
and supplemented by the following instruments: Montreal
Cognitive Assessment (MOCA) ≤18 points [27], Dementia
Rating Scale-2 (DRS-2) ≤ 124 points [28] , and the Center
for Epidemiological Studies - Depression (CES-D) ≥ 16
points [29]. In addition, exclusion criteria for the use of
cortical stimulation will be applied: a) use of drugs
stimulating central nervous system activity; b) patients
with implanted metallic or electronic devices; c) a
cardiac pacemaker; d) patients who experience seizures/
convulsions; and e) pregnancy.
Intervention
A constant current stimulator (TCT Research Limited)
will be used using electrodes of 5 × 5 cm2 embedded in
saline (0.9 % NaCl) and application of 2 mA current for
20 minutes. The protocol is identical for placebo stimu-
lation, but the current will stop after 30 seconds from
the start of stimulation, a blinding method used in sev-
eral previous studies [1, 15].
The positioning of the electrodes follows the 10–20
electroencephalogram (EEG) system model. The cathode
will be positioned in the right supra-orbital region (contra-
lateral to vascular injury), while the anode will have the fol-
lowing provision in the left hemisphere: group 1 (dlPFC),
F3 position [30]; group 2, cingulo-opercular network
(CON)-anterior insula/frontal operculum, the intersection
point between T3-Fz and F7-Cz [31, 32]; and groups 3 and
4, M1 position [33].
All experiments will be conducted at the same time of
day (afternoon shift), including stimulation and evaluation,
to avoid possible circadian cycle influences.
Procedures
The primary outcome of the study will be the Dysexecu-
tive Questionnaire (DEX) [34], composed of 20 subtests,
standardized, with total score ranging from 0 to 80
points, applied to the patient and a family member. The
issues involve disturbances in executive functions such
as emotional or personality, motivational, behavioral and
cognitive changes. It is an instrument with ecological
validity confirmed for patients with brain injuries and
may provide important information on executive func-
tions with implications for cognitive rehabilitation [35].
Secondary outcomes will be: the Semantic Fluency Test
(FAS), which assesses the recall of words that begin with a
certain letter and category fluency for the generation of
words in a semantic class [36]; Go-no go, which tests self-
monitoring, inhibition, initiation and cognitive flexibility
[37]; Wechsler Intelligence Scale for Adults (WAIS), in the
subtests of digit symbol coding, matrix reasoning, compre-
hension and letter-number sequencing for evaluation of
executive functions [38]; Rey Auditory Verbal Learning
(RAVLT) test that measures recent memory, learning,
interference, retention and recognition memory [39];
Letter Comparison and Pattern Comparison Tasks [40].
Safety
To control adverse effects, reports of patients with feel-
ings/sensations of itching, tingling, burning, headache or
other discomfort (1 none, 2 mild, 3 moderate, or 4
strong) will be recorded, along with whether this effect
could be related to stimulation on a Likert scale; 1 (no
relation) to 5 (strongly related).
If any damage/injury occurs to the participant, he or
she will be offered medical assistance/treatment, physio-
therapy and psychological care without any onus or cost
to the participant.
Statistical analysis
To determine the number of participants in each group,
we will apply the proposed criteria for clinical trials. As
observed in previous studies using the DEX for cognitive
evaluation, we found that the average obtained by indi-
viduals with cognitive decline (without presence of de-
mentia) undergoing rehabilitation protocols lies in a
range of 15 to 17 points, with a deviation-pattern of 5.0
to 8.0 points [41–43]. The minimal importance differ-
ence will be considered based on the variation of the
standard error of measurement approach, considering 1
for a small effect, 1.96 for a moderate and 2.77 for a
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large effect [14]. From these criteria, considering 90 %
power and taking into account possible dropouts, we
calculate a final sample size of 90 participants. A signifi-
cance level of P <0.05 will be considered.
An analysis of intention to treat will be used, and sen-
sitivity analysis will be performed with different alloca-
tion procedures to verify the strength of the data. The
best strategy resulting from the comparison of the fol-
lowing methods will be chosen: last observation carried
forward, complete-case analysis, likelihood-based methods
and multiple imputation.
For the primary endpoint, we will use a mixed linear
model. We will model the change in cognitive perform-
ance according to the DEX using the covariates of time,
group and interaction between treatment and time. The
covariance with repeated measures and for each patient
will also be measured. For secondary outcomes, repeated
measures analysis of variance (ANOVA) will be used in
which the dependent variable is the performance in each
cognitive test and the independent variables are group
(dlPFC, CON, M1, or sham), treatment time (baseline/
initiation, week 2 and follow-up) and interaction group ×
treatment time. If necessary, post-hoc comparisons using
Bonferroni correction will be made.
Deleterious and adverse cognitive effects will be calcu-
lated in terms of the proportion in each group and in
each period, and will be analyzed by the Fisher exact test.
Discussion
The primary objective of the study is to determine
whether stimulation of the dlPFC and CON affects cog-
nition in patients after a stroke. In addition, we seek to
examine whether these effects are similar to each other
and what is the clinical significance of the identified
changes. Although studies with noninvasive stimulation
focused on patients with cognitive dysfunction are import-
ant, completing a long-term follow up of participants who
suffer strokes is a possibility for new advances in terms of
prognosis. Traditionally, they would only have access to
motor rehabilitation.
Some work has been published in order to explore the
role that these two dlPFC and CON networks play [44].
However, clinical evidence related to the function of these
two areas in terms of strategies for decision-making and
other real life situations has been compromised [45]. In
order to compare the effects of neurostimulation at these
two sites, we propose to identify recovery markers through
standardized assessment protocols.
In general, the strengths of our study include the
following: 1) proposing a new approach of different
stimulation from the classical cognitive approach after a
stroke; 2) conduct longitudinal monitoring of responses
to therapy, measuring potential neuroplastic benefits; 3)
employing rehabilitation that is easy to use, low cost,
safe and feasible; and 4) characterize cognitive markers
as predictors of response.
Nevertheless, we can cite the insertion of chronic pa-
tients as a constraint, which limits the generalization to
other phases of the stroke. Because there are cognitive
and sensorimotor differences in the various phases of a
stroke, it was decided to choose one of them, for greater
control of the data. This, however, does not preclude the
conduct of future studies that compare patients in differ-
ent stages in order to know at what time after the injury
stimulation could be more effective. Furthermore, the
treatment will be performed in the laboratory, which can
result in losses or withdrawals by participants. To minimize
these effects, adherence strategies will be employed (direct
and frequent contact with patients, scheduling flexibility
and reinforcement of the importance of care continuity).
Another important aspect is that during the repeated
measures application of neuropsychological tests, ceiling
effects may occur, which will reduce the longer the inter-
val between assessments; conversely, there will be a
greater risk of changes in the characteristic being mea-
sured. In this study, the constructs analyzed did not ex-
press significant volatility over time, and the assessment
range was based on standardization applied in previous
studies involving neurostimulation and cognitive as-
sessment [33, 46]. Thus, our study provides important
implications for rehabilitation, both in the theoretical
aspect to support new trials and also in a clinical
setting to provide evidence to be applied in treating
patients.
Trial status
Recruitment and interventions are in progress.
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